Y
Yan Li
Researcher at Fourth Military Medical University
Publications - 187
Citations - 4349
Yan Li is an academic researcher from Fourth Military Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 33, co-authored 148 publications receiving 3127 citations. Previous affiliations of Yan Li include Xi'an Jiaotong University.
Papers
More filters
Journal ArticleDOI
Cell-free therapy based on adipose tissue stem cell-derived exosomes promotes wound healing via the PI3K/Akt signaling pathway.
Wei Zhang,Xiaozhi Bai,Bin Zhao,Yan Li,Yijie Zhang,Zhenzhen Li,Xujie Wang,Liang Luo,Fu Han,Julei Zhang,Shichao Han,Weixia Cai,Linlin Su,Ke Tao,Jihong Shi,Dahai Hu +15 more
TL;DR: It is demonstrated that ADSC‐derived exosomes can promote fibroblast proliferation and migration and optimize collagen deposition via the PI3K/Akt signaling pathway to further accelerate wound healing.
Journal ArticleDOI
The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA-26a.
Yan Li,Longkun Fan,Shiyu Liu,Wenjia Liu,Hao Zhang,Tao Zhou,Dan Wu,Ping Yang,Lijuan Shen,Jihua Chen,Yan Jin +10 more
TL;DR: Host specific real-time PCR test of the neo-formed bone demonstrated that miR-26a optimized bone regeneration mainly due to simultaneously regulating endogenous angiogenesis-osteogenesis coupling, providing evidence that miRNA-based therapy can be a valuable tool to promote bone regeneration.
Journal ArticleDOI
Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy.
Lang Hu,Mingge Ding,Daishi Tang,Erhe Gao,Congye Li,Kaiyan Wang,Bingchao Qi,Jihuan Qiu,Huishou Zhao,Pan Chang,Feng Fu,Yan Li +11 more
TL;DR: This study provides the first evidence that imbalanced mitochondrial dynamics induced by down-regulated Mfn2 contributes to the development of diabetic cardiomyopathy (DCM).
Journal ArticleDOI
MiRNA-29b suppresses tumor growth through simultaneously inhibiting angiogenesis and tumorigenesis by targeting Akt3.
Yan Li,Bolei Cai,Liangliang Shen,Yan Dong,Qun Lu,Shukai Sun,Shiyu Liu,Shufang Ma,Peter X. Ma,Jihua Chen +9 more
TL;DR: The role of miR-29b in anti-angiogenesis and anti-tumorigenesis is demonstrated is through targeting Akt3 and inducing VEGF and C-myc arrest in breast cancer cells, indicating that this single miRNA could be used as an efficient anti-cancer therapeutic agent to address a critical challenge in cancer therapy.
Journal ArticleDOI
Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated Akt and caspase-9.
TL;DR: It is shown that resveratrol affects the growth of human breast cancer cell lines MCF7, MDA-MB-231, SK-BR-3, and Bcap-37 in a dose-dependent manner and thatMCF7 is the most sensitive among the four cell lines.